|
US7029702B2
(en)
*
|
1998-07-07 |
2006-04-18 |
Ritter Natural Sciences Llc |
Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
|
|
SE523771C2
(sv)
*
|
1999-05-21 |
2004-05-18 |
Probi Ab |
Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
|
|
EP1290136B1
(en)
*
|
2000-05-25 |
2006-05-10 |
Société des Produits Nestlé S.A. |
Probiotics for pet food applications
|
|
SE0003100D0
(sv)
*
|
2000-09-01 |
2000-09-01 |
Probi Ab |
New strains
|
|
SE0003576D0
(sv)
*
|
2000-10-04 |
2000-10-04 |
Probi Ab |
New strain
|
|
KR100419132B1
(ko)
*
|
2000-12-29 |
2004-02-18 |
조성근 |
위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:h7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이csk 01
|
|
SE0103695D0
(sv)
|
2001-11-07 |
2001-11-07 |
Thomas Boren |
A novel non-antibiotic strategy against OGIP infections based on a cereal product
|
|
WO2003080813A2
(en)
|
2002-03-21 |
2003-10-02 |
Bifodan A/S |
Lactobacillus strains
|
|
JP4308481B2
(ja)
*
|
2002-06-18 |
2009-08-05 |
独立行政法人農業・食品産業技術総合研究機構 |
抗アレルギー剤
|
|
US20040057943A1
(en)
|
2002-06-28 |
2004-03-25 |
Jordi Xaus Pey |
Probiotic strains, a process for the selection of them, compositions thereof, and their use
|
|
EP1384483A1
(en)
*
|
2002-07-23 |
2004-01-28 |
Nestec S.A. |
Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
|
|
JP2004189672A
(ja)
*
|
2002-12-11 |
2004-07-08 |
Gen Corp:Kk |
抗下痢症組成物
|
|
TWI324068B
(en)
*
|
2003-03-13 |
2010-05-01 |
Kirin Holdings Kk |
Antiallergic composition
|
|
MXPA05010696A
(es)
*
|
2003-04-02 |
2006-04-18 |
Axcan Pharma S A |
Cepa de lactobacillus fermentum y usos de la misma.
|
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
MY143693A
(en)
|
2004-03-24 |
2011-06-30 |
Nestec Sa |
Shelf stable product wih living micro-organisms
|
|
ITRM20040166A1
(it)
*
|
2004-03-31 |
2004-06-30 |
Alberto Cresci |
Ceppi batterici lab con proprieta' probiotiche e composizioni che contengono gli stessi.
|
|
WO2006012536A2
(en)
*
|
2004-07-22 |
2006-02-02 |
Ritter Andrew J |
Methods and compositions for treating lactose intolerance
|
|
TW200637908A
(en)
*
|
2005-01-04 |
2006-11-01 |
Calpis Co Ltd |
Method for preparation of lactic acid bacterium having anti-allergic activity
|
|
EP1926395A1
(en)
|
2005-04-13 |
2008-06-04 |
Nestec S.A. |
Infant formula with probiotics
|
|
US20060263311A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Scavone Timothy A |
Consumer noticeable improvement in wetness protection using solid antiperspirant compositions
|
|
WO2006130187A1
(en)
|
2005-05-31 |
2006-12-07 |
The Iams Company |
Feline probiotic lactobacilli
|
|
EP1885383B1
(en)
|
2005-05-31 |
2016-09-21 |
IAMS Europe B.V. |
Feline probiotic bifidobacteria
|
|
AU2006297896B2
(en)
*
|
2005-10-06 |
2011-12-08 |
Probi Ab |
Use of lactobacillus for treatment of autoimmune diseases
|
|
RU2445362C2
(ru)
|
2006-02-15 |
2012-03-20 |
Нестек С.А. |
Применение bifidobacterium longum в производстве лекарственного средства или терапевтической питательной композиции для лечения воспалительного заболевания кишечника у млекопитающего и для ослабления воспаления кишечника, связанного с пищевыми аллергенами, у млекопитающего
|
|
MY149913A
(en)
|
2006-03-07 |
2013-10-31 |
Nestec Sa |
Synbiotic mixture
|
|
EP1952703B1
(de)
*
|
2007-02-02 |
2010-08-25 |
May, Amadeus Alexander |
Produkt mit lebenden probiotischen Mikroorganismen
|
|
EP1974735A1
(en)
*
|
2007-03-28 |
2008-10-01 |
Nestec S.A. |
Reduction of risk of diarrhoea
|
|
CN101273736B
(zh)
*
|
2007-03-28 |
2012-08-08 |
北京弗蒙特生物技术有限公司 |
一种在常温下保持高活菌数的发酵乳的制备方法
|
|
EP1974743A1
(en)
|
2007-03-28 |
2008-10-01 |
Nestec S.A. |
Probiotics to Improve Gut Microbiota
|
|
PT2173196E
(pt)
*
|
2007-07-06 |
2011-05-23 |
Nutricia Nv |
Uso de probi?ticos e fibras para a diarreia
|
|
US20090110663A1
(en)
*
|
2007-10-24 |
2009-04-30 |
Halow George M |
Method for treatment of bowel disorders
|
|
EP2072052A1
(en)
|
2007-12-17 |
2009-06-24 |
Nestec S.A. |
Prevention of opportunistic infections in immune-compromised subjects
|
|
UA101176C2
(ru)
|
2008-01-24 |
2013-03-11 |
Нестек С.А. |
Капсула для применения в устройстве для приготовления напитков, которая содержит питательные ингредиенты и способ получения питательной жидкости из капсулы
|
|
PT2265135T
(pt)
|
2008-03-14 |
2018-02-21 |
Nestec Sa |
Mistura simbiótica
|
|
EP2127661A1
(en)
|
2008-05-27 |
2009-12-02 |
Nestec S.A. |
Probiotics to improve gut microbiotica
|
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
|
US20110189148A1
(en)
*
|
2008-06-25 |
2011-08-04 |
Ritter Pharmaceuticals, Inc. |
Lactose compositions with decreased lactose content
|
|
EP2147678A1
(en)
|
2008-07-21 |
2010-01-27 |
Nestec S.A. |
Probiotics to increase IgA secretion in infants born by caesarean section
|
|
EP2166083B1
(en)
*
|
2008-12-31 |
2010-12-22 |
Syngen biotech CO., LTD. |
Novel Lactobacillus paracasei subsp. paracasei SG96, a bacteriostatic composition containing the same and use thereof
|
|
US20100196341A1
(en)
*
|
2009-02-05 |
2010-08-05 |
Syngen Biotech Co., Ltd. |
Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof
|
|
US8785160B2
(en)
|
2009-02-24 |
2014-07-22 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
|
SG10201901259RA
(en)
|
2009-02-24 |
2019-03-28 |
Ritter Pharmaceuticals Inc |
Prebiotic formulations and methods of use
|
|
MX338680B
(es)
*
|
2009-05-11 |
2016-04-27 |
Nestec Sa |
Bifidobacterium longum ncc2705 (cncm i-2618) y padecimientos inmunes.
|
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
|
US9226521B2
(en)
|
2009-12-08 |
2016-01-05 |
Nestec S.A. |
Infant formula with probiotics and milk fat globule membrane components
|
|
EP2510932A1
(en)
*
|
2011-04-15 |
2012-10-17 |
Nestec S.A. |
Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
|
|
ES3005933T3
(en)
|
2011-06-20 |
2025-03-17 |
Heinz Co Brands H J Llc |
Probiotic compositions and methods
|
|
ES3010649T3
(en)
|
2012-06-18 |
2025-04-04 |
Heinz Co Brands H J Llc |
Gluten-related disorders
|
|
MX370692B
(es)
*
|
2013-05-10 |
2019-12-19 |
Heinz Co Brands H J Llc |
Probióticos y métodos de uso.
|
|
AU2015357549B2
(en)
|
2014-12-05 |
2022-03-24 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
US9688967B2
(en)
|
2014-12-05 |
2017-06-27 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
EP3940067A1
(en)
|
2014-12-05 |
2022-01-19 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
WO2016183532A1
(en)
|
2015-05-13 |
2016-11-17 |
Synlogic, Inc. |
Bacteria engineered to treat a disease or disorder
|
|
US20160206666A1
(en)
|
2014-12-22 |
2016-07-21 |
Synlogic, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
|
|
JP7095993B2
(ja)
|
2015-03-02 |
2022-07-05 |
シンロジック オペレーティング カンパニー インコーポレイテッド |
消化管炎症低下および/または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌
|
|
CA2985819A1
(en)
|
2015-05-13 |
2016-11-17 |
Synlogic, Inc. |
Bacteria engineered to reduce hyperphenylalaninemia
|
|
CA2988930A1
(en)
|
2015-06-10 |
2016-12-15 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
WO2016210373A2
(en)
|
2015-06-24 |
2016-12-29 |
Synlogic, Inc. |
Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
|
|
WO2016210384A2
(en)
|
2015-06-25 |
2016-12-29 |
Synlogic, Inc. |
Bacteria engineered to treat metabolic diseases
|
|
WO2016210378A2
(en)
|
2015-06-25 |
2016-12-29 |
Synlogic, Inc. |
Multi-layered control of gene expression in genetically engineered bacteria
|
|
JP2018521674A
(ja)
|
2015-07-31 |
2018-08-09 |
シンロジック オペレーティング カンパニー インコーポレイテッド |
プロピオネート異化を伴う障害を治療するために操作された細菌
|
|
EP3344266A1
(en)
|
2015-08-31 |
2018-07-11 |
Synlogic, Inc. |
Bacteria engineered to treat disorders in which oxalate is detrimental
|
|
WO2017075485A1
(en)
|
2015-10-30 |
2017-05-04 |
Synlogic, Inc. |
Bacteria engineered to treat disorders in which trimethylamine (tma) is detrimental
|
|
US11685925B2
(en)
|
2015-10-30 |
2023-06-27 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
|
EP3368696A1
(en)
|
2015-10-30 |
2018-09-05 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
|
US11618894B2
(en)
|
2015-11-16 |
2023-04-04 |
Synlogic Operating Company, Inc. |
Bacteria engineered to reduce hyperphenylalaninemia
|
|
CA3011283A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic Operating Company, Inc. |
Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
|
|
WO2017123676A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof
|
|
WO2017123592A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Bacteria engineered to treat disorders associated with bile salts
|
|
WO2017123610A2
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Bacteria engineered to detoxify deleterious molecules
|
|
WO2017123418A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Bacteria engineered to treat metabolic diseases
|
|
WO2017136792A2
(en)
|
2016-02-04 |
2017-08-10 |
Synlogic, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
|
WO2017136795A1
(en)
|
2016-02-04 |
2017-08-10 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with tryptophan metabolism
|
|
WO2017139697A1
(en)
|
2016-02-10 |
2017-08-17 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
WO2017139708A1
(en)
|
2016-02-10 |
2017-08-17 |
Synlogic, Inc. |
Bacteria engineered to treat nonalcoholic steatohepatitis (nash)
|
|
WO2017194650A1
(en)
*
|
2016-05-11 |
2017-11-16 |
Chr. Hansen A/S |
Lactic acid bacteria for a heat-treated food product for storage at ambient temperature
|
|
JP2020505016A
(ja)
|
2017-01-06 |
2020-02-20 |
シンロジック オペレーティング カンパニー インコーポレイテッド |
腫瘍細胞において免疫モジュレーターおよび抗がん治療剤を産生するようにプログラムされた微生物
|
|
US10941433B2
(en)
|
2017-06-15 |
2021-03-09 |
Iowa State University Research Foundation, Inc. |
Neurotransmitter transport in probiotics
|
|
CN111655841A
(zh)
|
2017-06-21 |
2020-09-11 |
同生运营公司 |
用于治疗紊乱的细菌
|
|
CA3066109A1
(en)
|
2017-07-12 |
2019-01-17 |
Synlogic Operating Company, Inc. |
Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
|
|
US20210130806A1
(en)
|
2017-11-03 |
2021-05-06 |
Synlogic Operating Company, Inc. |
Engineered bacteria expressing racemase for treating diseases associated with hyperammonemia
|
|
CN110960559B
(zh)
*
|
2018-09-30 |
2021-02-26 |
内蒙古伊利实业集团股份有限公司 |
用于抑制口腔病原菌的乳酸菌菌株的食品、口腔清洁以及医药组合物
|
|
WO2020063531A1
(zh)
|
2018-09-30 |
2020-04-02 |
内蒙古伊利实业集团股份有限公司 |
副干酪乳杆菌et-22及其用途
|
|
US20220257732A1
(en)
|
2019-04-29 |
2022-08-18 |
Synlogic Operating Company, Inc. |
Enumeration of genetically engineered microorganisms by live cell counting techniques
|
|
WO2021013862A1
(en)
|
2019-07-23 |
2021-01-28 |
Frieslandcampina Nederland B.V. |
Nutritional composition comprising milk fat and immunoglobulin
|
|
BR112022005578A2
(pt)
|
2019-09-24 |
2022-09-20 |
Prolacta Bioscience Inc |
Composições e métodos para tratamento de doenças inflamatórias e imunes
|
|
EP4081229A1
(en)
|
2019-12-24 |
2022-11-02 |
Iowa State University Research Foundation, Inc. |
Control of histamine to promote health and control enterocolitis using probiotic compositions and/or histamine degrading enzymes
|
|
CN113355252A
(zh)
*
|
2020-03-06 |
2021-09-07 |
南京卫岗乳业有限公司 |
一种副干酪乳杆菌及其应用
|
|
JP2023518184A
(ja)
|
2020-03-20 |
2023-04-28 |
シンロジック オペレーティング カンパニー インコーポレイテッド |
高フェニルアラニン血症を軽減するように遺伝子改変された微生物
|
|
CN116322371A
(zh)
|
2020-08-14 |
2023-06-23 |
普罗莱克塔生物科学公司 |
与细菌疗法一起使用的人乳寡糖组合物
|
|
WO2022120028A2
(en)
|
2020-12-02 |
2022-06-09 |
Synlogic Operating Company, Inc. |
Engineered microorganisms
|
|
CN116847860A
(zh)
|
2020-12-31 |
2023-10-03 |
同生运营公司 |
经工程化以减轻高苯丙氨酸血症的微生物
|
|
MX2023008227A
(es)
|
2021-01-12 |
2023-07-20 |
Prolacta Bioscience Inc |
Regimenes de tratamiento simbiotico.
|
|
CN112625983B
(zh)
*
|
2021-03-05 |
2021-05-28 |
山东中科嘉亿生物工程有限公司 |
一种对腹泻有治疗效果的干酪乳杆菌L.Casei21及其应用
|
|
CN112877260B
(zh)
*
|
2021-03-30 |
2022-08-09 |
江南大学 |
一株缓解泻剂结肠的副干酪乳杆菌及其应用
|
|
AU2022259522A1
(en)
|
2021-04-13 |
2023-10-19 |
Synlogic Operating Company, Inc. |
Bacteria engineered to secrete active proteins
|
|
CN115671144A
(zh)
*
|
2021-07-26 |
2023-02-03 |
锦乔生物科技有限公司 |
使用乳酸菌菌株的培养物来抑制肠道病原菌生长和预防和/或治疗与肠道病原菌有关的疾病
|
|
WO2023044479A1
(en)
|
2021-09-17 |
2023-03-23 |
Synlogic Operating Company, Inc. |
Methods for reducing hyperphenylalaninemia
|
|
WO2023245171A1
(en)
|
2022-06-17 |
2023-12-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
|
|
WO2023245168A1
(en)
|
2022-06-17 |
2023-12-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
|
|
CA3260270A1
(en)
|
2022-06-22 |
2023-12-28 |
Iowa State University Research Foundation, Inc. |
FIGHTING HISTAMINE TO PROMOTE HEALTH AND COMBAT ENTEROCOLITIS WITH PROBIOTIC COMPOUNDS
|
|
WO2023250478A1
(en)
|
2022-06-23 |
2023-12-28 |
Synlogic Operating Company, Inc. |
Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof
|
|
WO2024081768A1
(en)
|
2022-10-12 |
2024-04-18 |
Synlogic Operating Company, Inc. |
Bacteria engineered to produce active epidermal growth factor (egf) and their medical uses
|
|
JP2025534764A
(ja)
|
2022-10-17 |
2025-10-17 |
シンロジック オペレーティング カンパニー インコーポレイテッド |
高フェニルアラニン血症を軽減するためのフェニルアラニンアンモニアリアーゼ、フェニルアラニントランスポーターおよびl-アミノ酸デアミナーゼを発現する組み換え細菌
|
|
WO2024129974A1
(en)
|
2022-12-14 |
2024-06-20 |
Synlogic Operating Company, Inc. |
Recombinant bacteria for use in the treatment of disorders in which oxalate is detrimental
|
|
WO2024130119A2
(en)
|
2022-12-16 |
2024-06-20 |
Prolacta Bioscience, Inc. |
Synbiotic compositions for short chain fatty acid production
|
|
EP4647439A1
(en)
|
2024-05-09 |
2025-11-12 |
Alma Mater Studiorum - Università di Bologna |
Non-pathogenic bacteria for delivery of ptd-fusion proteins
|